Search Results
Found 2 results
510(k) Data Aggregation
(28 days)
Percuflex Ureteral Stent; Percuflex Plus Ureteral Stent; Percuflex Plus SureDrive Steerable Ureteral
The Ureteral Stents are intended to facilitate urinary drainage from the kidney to the bladder via placement endoscopically or fluoroscopically by a trained physician.
The Urinary Diversion Stent Sets are intended to provide external drainage of urine after urinary diversion surgeries.
The Ureteral Stents are sterile, single use, disposable devices that provide a lumen that allows fluids to move from the kidney to the bladder. The Ureteral Stents are provided in multiple French sizes and lengths.
The Urinary Diversion Stent Sets are sterile, single use, disposable devices that allow internal drainage from the kidney to an external collection system.
Based on the provided FDA 510(k) clearance letter for the Boston Scientific Corporation's Ureteral Stents and Urinary Diversion Stent Sets (K250824), it's important to note that no study or specific performance criteria are detailed in this document.
This 510(k) is a "Special 510(k) ", which is used when changes to a legally marketed device do not affect its safety or effectiveness. The key takeaway from Section J (Performance Testing) and Section I (Substantial Equivalence) is:
- Changes are limited to labeling updates. The submission explicitly states: "The changes proposed within this bundled Special 510(k) are to the labeling for the proposed devices. There are no changes in design, performance, operating principle, or fundamental technology being proposed within this premarket notification."
- No new testing was required: "Therefore, existing test information/data remains valid for the proposed devices. No additional Verification or Validation testing was required for the changes to the labeling."
- Substantial Equivalence based on existing data: The conclusion reiterates that "Based on the intended use/indications for use, operating principle and comparison of key technological characteristics presented in this premarket notification, it is concluded that the proposed Ureteral Stents and Urinary Diversion Stent Set are substantially equivalent to the predicate device (cleared under K190603)."
Therefore, the document does not contain the information required to populate the sections you requested regarding acceptance criteria and a study proving the device meets those criteria, because no new performance testing was conducted for this specific 510(k) submission.
Here is a table explaining why each of your requested points cannot be answered from this specific 510(k) submission:
Information Requested | Explanation based on K250824 Document |
---|---|
1. A table of acceptance criteria and the reported device performance | Not applicable. This submission is for labeling changes only; no new performance data or acceptance criteria for new testing are provided. The device relies on prior clearance (K190603) for its performance. |
2. Sample sized used for the test set and the data provenance (e.g., country of origin, retrospective or prospective) | Not applicable. No new test set was used for this Special 510(k) as no new performance testing was performed. |
3. Number of experts used to establish the ground truth for the test set and qualifications of those experts | Not applicable. No new test set, and thus no new ground truth establishment process, was conducted for this submission. |
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set | Not applicable. As no new test set was used, no adjudication method was employed. |
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance | Not applicable. This device is a physical medical device (stent), not an AI/software device that would typically undergo MRMC studies or assist human readers. Furthermore, no new studies were performed. |
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done | Not applicable. This is a physical medical device, not an algorithm. No new standalone performance testing was conducted. |
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.) | Not applicable. No new ground truth was established as no new performance testing was conducted. For the predicate device, the ground truth would have been established through methods appropriate for medical devices such as bench testing, biocompatibility, and potentially clinical data from prior predicate devices. |
8. The sample size for the training set | Not applicable. This device is not an AI/ML algorithm that requires a training set. No new data generation was part of this submission. |
9. How the ground truth for the training set was established | Not applicable. This device is not an AI/ML algorithm that requires a training set. |
In summary, the provided 510(k) document (K250824) is a regulatory clearance for minor changes (specifically labeling updates) to existing, already cleared medical devices. It explicitly states that these changes do not require new performance testing, and therefore, it does not contain the details of studies, acceptance criteria, or ground truth establishment that would be present in an original 510(k) submission for a novel device or a device with significant design changes or a software/AI component. The "proof" of meeting acceptance criteria for these devices relies on the data submitted and reviewed for the predicate device (K190603).
Ask a specific question about this device
(448 days)
Percuflex Ureteral Stent System, Percuflex Ureteral Stent System Kit, Percuflex Nephroureteral Stent
Percuflex™ Ureteral Stent System and Percuflex™ Ureteral Stent System Kit: The Ureteral Stent is intended to provide drainage from the ureteropelvic junction to the bladder and stenting of the ureter for all patients in whom it is desirable to place a drain which does not externally.
Percuflex™ Nephroureteral Stent System: The Percuflex Nephroureteral Stent is intended for use in Percutaneous Drainage to establish internal drainage from the ureteropelvic junction to the bladder while maintaining external access to the stent.
Amplatz Anchor™ Catheter System: The Amplatz Anchor™ Catheter System is intended for use in applications of percutaneous drainage, particularly percutaneous nephrostomy, abscess or external biliary drainage.
The Percuflex™ Ureteral Stent System and Percuflex™ Ureteral Stent System Kit is designed with the classic pigtail shape on each end and is intended to facilitate drainage internally from the renal pelvis to the bladder and stenting of the ureter without external access after placement. The ureteral stent systems contain a suture to adjust the pigtail shape or to remove the stent. These devices are constructed of a proprietary, biocompatible copolymer called Percuflex™ for patient comfort with a radiopaque resin throughout the catheter tube. Designated Percuflex™ Ureteral Stent Systems are also available with a proprietary Glidex™ hydrophilic material for the reduction of surface friction during placement or with a dissolving distal tip (Temp-Tip™). The dissolving tip internal diameter aids in placement, then dissolves soon after placement to allow a larger lumen for drainage.
The Percuflex™ Nephroureteral Stent System is also designed with the classic pigtail shape on each end and facilitates drainage from the internal ureteropelvic junction to the bladder with external access to the stent. The Nephroureteral Stent System also incorporates the Percuflex™ copolymer and a radiopaque resin throughout the catheter tube. Select models are available with a Temp-Tip™ which dissolves soon after placement. A suture is locked in place with a stopcock to retain the pigtail shape. A luer allows for connection to other drainage devices with a conical fitting.
The Amplatz Anchor™ Catheter System is designed with a unique locking Malecot diamond shape to facilitate percutaneous nephrostomy, abscess or external biliary drainage. The Amplatz Anchor™ Catheter Systems also incorporate the Percuflex™ copolymer and a radiopaque resin throughout the catheter tube. A suture is locked in place with a stopcock to retain the 2-winq design. A luer allows for connection to other drainage devices with a conical fitting.
These Percuflex™ Drainage Catheters and Stents are provided sterile, using 100% ethylene oxide (EO) gas sterilization, and are intended for hospital and single use only. Where long-term use is indicated, it is recommended not to exceed 90 days of indwelling time.
The provided text describes a 510(k) premarket notification for the Boston Scientific Percuflex Drainage Catheters and Stents, asserting their substantial equivalence to a predicate device (K924608). The document focuses on non-clinical performance testing conducted to support new Magnetic Resonance (MR) compatibility information and cumulative internal changes to the devices.
1. Table of Acceptance Criteria and Reported Device Performance
The document does not explicitly present a table of acceptance criteria with corresponding performance metrics in a pass/fail format, nor does it specify exact numerical thresholds for "acceptance criteria." Instead, it lists the types of non-clinical tests performed and states that these tests demonstrate "the subject devices are as safe and effective as the predicate devices" and that the changes "do not raise new questions of safety or effectiveness."
However, we can infer the categories of acceptance criteria based on the tests conducted:
Acceptance Criteria Category | Reported Device Performance / Assessment |
---|---|
Magnetic Resonance (MR) Compatibility | |
Radio Frequency (RF) Heating | Testing performed per ASTM F2182-11a. The submission implies that the results are acceptable, allowing for the addition of MR compatibility information to the Directions for Use without raising new safety/effectiveness questions. Specific numerical values are not provided. |
Force Measurement (Displacement) | Testing performed per ASTM F2052-14. The submission implies that the results are acceptable, allowing for the addition of MR compatibility information to the Directions for Use without raising new safety/effectiveness questions. Specific numerical values are not provided. |
Image Artifact | Testing performed per ASTM F2119-07. The submission implies that the results are acceptable, allowing for the addition of MR compatibility information to the Directions for Use without raising new safety/effectiveness questions. Specific numerical values are not provided. |
Material Changes & Biocompatibility | |
Material Evaluation (Resin additive) | Fourier Transform Infrared Spectroscopy (FTIR), Differential Scanning Calorimetry (DSC), Thermogravimetric Analysis (TGA), Oxidative Induction Time (OIT), and Dynamic Contact Angle (DCA) analysis performed. Results "demonstrated that both supplied resins present the same thermal transition characteristics, material type (chemistry), and composition." |
Design Verification (Resin additive) | Catheter Shaft Tensile, Column Strength, Kink Resistance, and Removal Force testing performed. Renal Coil Resistance-Stent Shaft >5F also performed. The submission indicates these assessed finished device properties were maintained. Specific numerical thresholds or results are not provided. |
Biocompatibility (Resin additive) | Testing performed per ISO 10993-1, including Cytotoxicity, Sensitization, Intracutaneous irritation, Material mediated pyrogenicity, Acute systemic toxicity, Genotoxicity (Ames and MLA assays), Muscle implantation (4-week and 13-week studies). A Toxicological Risk Assessment was also performed. The submission implies all tests showed acceptable biocompatibility. |
Tensile Performance Specification Update | |
Dissolving Tip to Shaft Bond | Design verification testing conducted on aged and unaged samples. The submission states this demonstrated "the dissolving tip to shaft bond design output continues to meet the defined design input requirements after sterilization." Specific numerical thresholds or results are not provided. |
2. Sample Size Used for the Test Set and Data Provenance
The provided document describes non-clinical performance testing, primarily bench testing and material characterization. It does not mention human subject testing or clinical data. Therefore:
- Sample Size for Test Set: Not applicable in terms of patient samples. The sample sizes for the in vitro or material tests (e.g., number of stent units tested for tensile strength, number of material samples for FTIR) are not specified in this summary.
- Data Provenance: Not applicable in terms of country of origin for clinical data or retrospective/prospective studies, as no clinical studies are presented. The tests conducted are laboratory-based.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications
Not applicable. Ground truth, in the context of diagnostic performance measured against clinical expert consensus or pathology, is not relevant here as this document describes non-clinical, benchtop, and material science testing of a medical device (stent and catheter systems), not a diagnostic algorithm.
4. Adjudication Method for the Test Set
Not applicable. Adjudication methods (like 2+1, 3+1) are used to resolve disagreements among human annotators or readers when establishing ground truth for diagnostic studies. Such a process is not described or relevant for the non-clinical testing presented.
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This document is for a physical medical device (stents and catheters), not an AI/ML-driven diagnostic or assistive device. Therefore, no MRMC study or assessment of AI assistance to human readers was performed.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This is for a physical medical device, not an algorithm.
7. The Type of Ground Truth Used
The "ground truth" for the non-clinical tests described is inherent in the material science principles, engineering specifications, and established testing standards (e.g., ASTM, ISO 10993). For instance:
- For MR compatibility, the "ground truth" is compliance with the limits defined by ASTM standards for RF heating, displacement force, and image artifact.
- For material evaluation, the "ground truth" is that the new material performs identically to the old one in terms of chemical and physical properties as measured by standard analytical techniques.
- For biocompatibility, the "ground truth" is that the material elicits no adverse biological reactions based on ISO 10993 guidelines.
- For tensile strength, the "ground truth" is meeting predefined engineering specifications for strength and durability.
8. The Sample Size for the Training Set
Not applicable. This document describes non-clinical testing for a physical medical device, not the development or evaluation of an algorithm or AI system that requires a "training set."
9. How the Ground Truth for the Training Set was Established
Not applicable, as there is no training set mentioned or implied for this physical medical device.
Ask a specific question about this device
Page 1 of 1